Newsletter

BioMedReports OncoMed Offers Data from Demcizumab; Celgene Receives Positive CHMP Opinion For OTEZLA: Below is a look at som... http://t.co/ZkvEC7x99Y
BioMedReports Soaring generic drug prices draw Senate scrutiny... http://t.co/Fzq7h0GODI
BioMedReports Aeterna Zentaris Adds Hollings Cancer Center To Multi-National Phase 3 Trial; Marina and Mirna Amend License A... http://t.co/l3kFbpKB92
Benzinga.com supporter Seeking Alpha Certified